Shares of the South Korean biopharmaceutical company Celltrion rose 10% to 199,100 won. The company and Eli Lilly reached a $473 million contract manufacturing agreement.

Zhitongcaijing · 5d ago
Shares of the South Korean biopharmaceutical company Celltrion rose 10% to 199,100 won. The company and Eli Lilly reached a $473 million contract manufacturing agreement.